Vaxcyte PCVX
NASDAQ PCVX
$63.49 -2.74 (-4.14%)
As of: Oct 21, 2026 · 12:51 PM EDT

Vaxcyte (PCVX) Long-Term Debt Repayments (2019 - 2020)

Updated

Analysis

Vaxcyte (PCVX) Long-Term Debt Repayments (2019 - 2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,132.21 Bn 1,100.80 Bn 19.71 Bn 873.00 Mn
2 Johnson & Johnson 616.27 Bn 534.80 Bn 17.26 Bn 1.00 Mn
3 AbbVie 500.10 Bn 473.21 Bn 12.70 Bn 2.00 Bn
4 Merck 366.86 Bn 321.23 Bn 12.21 Bn 5.00 Mn
5 Novartis Ag 297.92 Bn 261.91 Bn 11.24 Bn 20.00 Mn
6 Astrazeneca 261.53 Bn 235.22 Bn 12.86 Bn 2.46 Bn
7 Amgen 234.99 Bn 190.39 Bn 7.24 Bn -
8 Gilead Sciences 190.14 Bn 164.34 Bn 6.22 Bn 17.00 Mn
9 Pfizer 169.63 Bn 116.28 Bn 10.94 Bn -
10 Vaxcyte 9.17 Bn 2.67 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2020 1,000.00
Mar 31, 2020 60,000.00
Dec 31, 2019 58,000.00
Sep 30, 2019 65,000.00
API Access

Vaxcyte Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=PCVX&period=max&api_key=YOUR_API_KEY